Archives

WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access

B Contributing to the United Nations Sustainable Development Goals, driving equitable access to healthcare through technology and innovation Enhancing governance transparency and effectiveness to create… Login to continue reading Login…

Read MoreWuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access

Qubs announces the availability of new Qubitunes games including Soundscapes, Jurassic Sounds and Qubi Quiz, previewed at international Toy Fairs

B OSLO, Norway, April 29, 2026 /PRNewswire/ — Building on the success of its award-winning Qubitunes screen-free audio gaming platform, Qubs has announced the availability… Login to continue reading Login…

Read MoreQubs announces the availability of new Qubitunes games including Soundscapes, Jurassic Sounds and Qubi Quiz, previewed at international Toy Fairs

Basta Receives $800,000 Grant from Carnegie Corporation of New York to Help First-Generation Students Secure Strong First Jobs

B The 24-month investment will help Basta reach more than 100,000 students, expand across four regions, and improve first-job outcomes for first-generation talent nationwide. NEW… Login to continue reading Login…

Read MoreBasta Receives $800,000 Grant from Carnegie Corporation of New York to Help First-Generation Students Secure Strong First Jobs

Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union

B Approval follows a positive opinion from the EMA’s Committee for Medicinal Products for Human Use (CHMP) EC approval marks a significant milestone for people… Login to continue reading Login…

Read MoreNorgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union